Value Sense
BGNE

BeiGene, Ltd. (BGNE)

Last Price$226.70.0%
Market Cap$1,846.9M
LTM Free Cash Flow margin
(30.4%)
5Y avg
(194.9%)
Biotechnology industry median
(735.0%)
Stock quality & Intrinsic value
5/10
11.4% undervalued
BGNE
is 1,137.7% undervalued
learn more -->
50+
undervalued stocks
Start beating the S&P 500

BeiGene, Ltd. Free Cash Flow margin

Annual
Quarterly
LTM
Industry median
Company stand-alone
BGNE
Healthcare
Crunching data... Almost there!
Dec'13Dec'14Dec'15Dec'16Dec'17Dec'18Dec'19Dec'20Dec'21Dec'22Dec'23
Free Cash Flow margin
34.2%
(71.7%)
(512.2%)
(10,562.1%)
(19.3%)
(347.4%)
(212.3%)
(489.7%)
(137.2%)
(138.8%)
(70.7%)
BGNE
Key metrics and insights to make informed decisions.
View full analysis
Overvalued or undervalued?
Check the intrinsic value for BGNE and see if it's the right time to invest.
Dive in

BeiGene, Ltd. (BGNE) Free Cash Flow margin comparison analysis

Crunching data... Almost there!

BGNE key stats

USD
Millions
Billions
Annual
Quarterly
Trailing
Key stats
Income statement
Balance sheet
Cash Flow Statement
Valuation
Ratios
Per share
Per employee
Dividends & Yields
Crunching data... Almost there!

Discover more Stock Ideas

Undervalued stocks right now

Undervalued stocks right now

Discover the top 20 best undervalued stocks to buy for Feb 2025, listed on the Nasdaq or NYSE.

3M Return 32.1%
S&P Outperformance 19.1%
Next 3M Predicted Return 20.3%
Undervalued growth stocks

Undervalued growth stocks

Discover the top 20 best undervalued large-cap growth stocks to buy for Feb 2025, listed on the Nasdaq or NYSE.

3M Return 35.3%
S&P Outperformance 22.3%
Next 3M Predicted Return 26.8%
Undervalued dividend stocks

Undervalued dividend stocks

Discover the top 20 best undervalued high-yield dividend stock that offers both growth potential and attractive dividend returns for Feb 2025.

3M Return 28.4%
S&P Outperformance 15.4%
Next 3M Predicted Return 16.9%
More ideas -->

FAQ

1) What is BeiGene, Ltd.'s Free Cash Flow margin?

As of today, Microsoft Corp's last 12-month Free Cash Flow margin is (30.4%), based on the financial report for Sep 30, 2024 (Q3 2024). The average annual Free Cash Flow margin for BeiGene, Ltd. have been (119.9%) over the past three years, and (204.7%) over the past five years.

2) Is BeiGene, Ltd.'s Free Cash Flow margin Good?

As of today, BeiGene, Ltd.'s Free Cash Flow margin is (30.4%), which is higher than industry median of (735.0%). It indicates that BeiGene, Ltd.'s Free Cash Flow margin is Good.

3) How does BeiGene, Ltd.'s Free Cash Flow margin compare to its peers?

As of today, BeiGene, Ltd.'s Free Cash Flow margin is (30.4%), which is lower than peer median of 24.7%. The list of peers includes SMMT, RPRX, UTHR, BNTX, REGN, NVO, INCY, ALNY, VRTX, ARGX.